An increased expression of somatostatin receptor SSTR5 has also been reported in a transcriptome analysis via the RNA sequencing of human ACTH-secreting adenoma cells, with potential therapeutic implications (i.e., possible different sensitivity to pasireotide) [26]. This evidence concerns the gene SSTR5 and adenoma.